In another study the results showed that exosomes derived from acute promyelocytic leukemia (APL) cells enhance the angiogenic capacity of ECs and thus prolong the survival of APL cells by delivering IL-8 and VEGF to ECs [124]. In addition to the direct transportation of proangiogenic factors, ...
Improved Survival Rates Among Acute Myeloid Leukemia (AML) Patients 65 to 74 Years: Population-Based Estimates Over Three Decades,Mya S TheinAhmedin JemalMaria R. BaerWilliam B ErshlerJerome W Yates
such as from X-rays or CT scans, especially at a very young age, may have an increased risk of leukemia. It's challenging to determine how much extra risk this gives you since it depends on what type of radiation you had, for how long, if it's repeated exposure, and how young ...
In a separate series, age is suggested to modify the effect of time with shorter interval from diagnosis to induction therapy (TDT) predicting improved OS in younger but not older AML patients. We retrospectively reviewed the Stanford Leukemia Database to validate the prognostic relevance of time ...
理论上讲,Hubbell的疫苗技术可以击溃一切肿瘤,真正实现"一物降万病魔"的宏愿。参考文献：Slezak, A. J., et al. (2024). Cysteine-binding adjuvant enhances survival and promotes immune function in a murine model of acute myeloid leukemia. Blood Advances. doi.org/10.1182/bloodadvances.2023012529.
The Treatment of Acute Myeloid Leukemia in First Relapse: A Comprehensive Review of the Literature Twenty years of published literature was reviewed for chemotherapy regimens used to treat patients with acute myeloid leukemia (AML) in first relapse. Thir... Leopold,Lance,H.,... - 《Leukemia & ...
AML中国诊疗指南AML部分.ppt,非移植患者10年生存率达37% N=202 43% 37% 总生存概率 1.0 0.8 0.6 0.4 0.2 0.0 时间 (年) 0 2 4 6 8 10 12 14 Eur J Haematol 2007; 78(6):477-486. 目前三十一页\总数五十五页\编于十点 非移植患者10年无复发生存率达32% N=195 40% 32% 无复发
In conclusion, lenalidomide treatment does not increase AML progression risk, but instead confers a possible survival benefit in RBC transfusion- dependent patients with del(5q) Low- or Int-1-risk MDS. Leukemia (2013) 27, 1072–1079; doi:10.1038/leu.2012.369 Keywords: Myelodysplastic syndromes; ...
Leukemia | 研究首次发现DDX11突变与细胞遗传学正常的AML复发相关 成果名称:在细胞遗传学正常的成人急性髓性白血病患者中,DEAD/H-box解旋酶11突变与复发风险增加相关 发表期刊:《白血病》[Leukemia,IF(2022):11.4] 通讯作者:黄晓军,阮国瑞 第一作者:周亚兰,赵鸣悦...
Until recently, acute myeloid leukemia (AML) patients used to have limited treatment options, depending solely on cytarabine + anthracycline (7 + 3) intensive chemotherapy and hypomethylating agents. Allogeneic stem cell transplantation (Allo